JCP
TECX

Jabre Capital Partners’s Tectonic Therapeutic TECX Stock Holding History

Jabre Capital Partners’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,458
Closed -$500K – 185
2018
Q2 		$500K Buy
+1,458
New +$526K 0.03% 120

Other funds holding TECX

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jabre Capital Partners's TECX Position: Q3 2018 in Review

Jabre Capital Partners sold out of Tectonic Therapeutic (TECX) in Q3 2018, closing a stake of 1,458 shares — an estimated $500K sold.

Jabre Capital Partners first reported a position in TECX in Q2 2018 and held it in 1 quarter. The position peaked at $500K in Q2 2018. 63 funds tracked by Wall St. Rank hold TECX as of Q3 2018.

  • Jabre Capital Partners reported no remaining Tectonic Therapeutic position as of Q3 2018 after selling out during the quarter.
  • Jabre Capital Partners sold 1,458 Tectonic Therapeutic shares in Q3 2018, an estimated $500K.
  • Jabre Capital Partners first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 1 quarter.
  • Jabre Capital Partners's Tectonic Therapeutic position peaked at $500K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2018.

Based on Jabre Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.